Industrial health research in Canada.
作者信息
Morin Yves
出版信息
CMAJ. 2007 Jun 5;176(12):1734; author reply 1734. doi: 10.1503/cmaj.1060190.
Abstract
摘要
相似文献
1
Industrial health research in Canada.加拿大的工业卫生研究。
CMAJ. 2007 Jun 5;176(12):1734; author reply 1734. doi: 10.1503/cmaj.1060190.
2
Gold in the ivory tower: equity rewards of outlicensing.象牙塔中的黄金：对外授权的股权回报
Nat Biotechnol. 2006 May;24(5):509-15. doi: 10.1038/nbt0506-509.
3
Research interactions between industry and academia: a corporate perspective.产业界与学术界之间的研究互动：企业视角。
Physiologist. 1996 Jun;39(3):81, 90-2.
4
Comparative effectiveness casts first shadows across US industry.比较效果研究给美国制药行业带来了首批阴影。
Nat Biotechnol. 2009 Mar;27(3):211-2. doi: 10.1038/nbt0309-211.
5
The policy outlook from the Hill.国会山的政策前景。
Nat Biotechnol. 2007 Jan;25(1):13-6. doi: 10.1038/nbt0107-13. Epub 2007 Jan 5.
6
The role of the private sector in biotechnology: research and development.私营部门在生物技术领域的作用：研发
Health Matrix Clevel. 2002 Summer;12(2):357-65.
7
Auctioning the cure.拍卖治疗方法。
Nat Med. 2011 May;17(5):528-30. doi: 10.1038/nm0511-528.
8
On the road to California.
Nature. 2002 Dec 12;420(6916 Suppl):A9.
9
Surprise US election results may boost biotech.美国意外的选举结果可能会推动生物技术行业发展。
Nat Biotechnol. 2002 Dec;20(12):1176. doi: 10.1038/nbt1202-1176a.
10
Biotechnology: delivering on the promise.生物技术：兑现承诺。
Sci Transl Med. 2010 Jan 6;2(13):13cm1. doi: 10.1126/scitranslmed.3000357.
本文引用的文献
1
Patent nonsense: evidence tells of an industry out of social control.专利闹剧：证据表明该行业已不受社会控制。
CMAJ. 2006 Aug 15;175(4):374. doi: 10.1503/cmaj.050575.
Zotero 插件